Inovio Pharmaceuticals (0A43.LSE) Q4 2023 Earnings

6MarConfirmed
Q4 2023
-1.19
-1.16
-1.13
-1.1

Details

Expected EPS
-1.186
Actual EPS
-1.1
Surprise EPS
0.09
Surprise Percent
+7.25%

Description

Inovio Pharmaceuticals (0A43.LSE) has reported earnings of -1.1 per share for Q4 2023.

0 Comments

Share your thoughts